Loading data
TMONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 44.56 bn USD | 42.88 bn USD | 42.86 bn USD | 44.92 bn USD | 39.21 bn USD |
| Research and development expense | 1.4 bn USD | 1.39 bn USD | 1.34 bn USD | 1.47 bn USD | 1.41 bn USD |
| Selling, general and administrative expense | 8.73 bn USD | 8.6 bn USD | 8.45 bn USD | 8.99 bn USD | 8.01 bn USD |
| Operating profit | 7.75 bn USD | 7.34 bn USD | 6.86 bn USD | 8.39 bn USD | 10.03 bn USD |
| Interest expense | — | — | 1.38 bn USD | 726 m USD | 536 m USD |
| Income tax expense | 547 m USD | 657 m USD | 284 m USD | 703 m USD | 1.11 bn USD |
| Net income (reported basis) | 6.72 bn USD | 6.34 bn USD | 5.96 bn USD | 6.96 bn USD | 7.73 bn USD |
| Net income attributable to common shareholders | — | 6.34 bn USD | 6 bn USD | 6.95 bn USD | 7.73 bn USD |
| Basic earnings per share | 17.77 USD/share | 16.58 USD/share | 15.52 USD/share | 17.75 USD/share | 19.62 USD/share |
| Diluted earnings per share | 17.74 USD/share | 16.53 USD/share | 15.45 USD/share | 17.63 USD/share | 19.46 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.